De coronapatenten en de druk van Johnson & Johnson op het kabinet van de eerste minister

This procedure concerns questions raised with the Belgian Prime Minister's office regarding COVID-19 vaccine patents and the actions of Johnson & Johnson. It highlights the intersection of public health, intellectual property, and government policy during a global pandemic. The questions likely impact public health strategies, pharmaceutical company responsibilities, and the government's role in addressing access to essential medicines.